Literature DB >> 18724149

A comparison of corneal endothelial cell changes after 1-site and 2-site phacotrabeculectomy.

Nader Nassiri1, Nariman Nassiri, Mohammad Rahnavardi, Laleh Rahmani.   

Abstract

PURPOSE: To compare the corneal endothelial cell (CEC) changes that occurred after phacotrabeculectomy performed at 1 or 2 sites.
DESIGN: A historical cohort study.
METHODS: The records of patients who had 1-site (n = 61) or 2-site (n = 52) limbus-based phacotrabeculectomy over a 4-year period (2002-2005) at 1 eye surgery center (Vanak Eye Surgery Center, Tehran, Iran) by a single surgeon were reviewed, and postoperative CEC indices were measured. Preoperative CEC indices, performed for a then-ongoing trial, were compared with postoperative measurements of the last follow-ups. The main outcome measure was endothelial cell count.
RESULTS: The median follow-up time was 12 months (range 9-24 months). There was no difference between the operations in improving visual acuity, lowering intraocular pressure, and decreasing the number of antiglaucoma medications required. However, 2-site surgery was associated with significantly more expansion in the CEC area (P < 0.001). On multivariate analysis, longer follow-up, 2-site surgery, and grade 4 cataract density were independently associated with more CEC loss, and longer follow-up, 2-site surgery, and steroid-induced glaucoma were associated with CEC area expansion. Postoperative complications were not markedly different between the 2 groups.
CONCLUSIONS: In both groups, the longer the follow-up time was, the higher the CEC loss and the CEC area expansion were. One-site surgery seems to cause less CEC damage than the 2-site operation during the median follow-up time of 1 year.

Entities:  

Mesh:

Year:  2008        PMID: 18724149     DOI: 10.1097/ICO.0b013e31817618b0

Source DB:  PubMed          Journal:  Cornea        ISSN: 0277-3740            Impact factor:   2.651


  6 in total

1.  Efficacy and tolerability of one-site versus two-site phacotrabeculectomy: a meta-analysis.

Authors:  He-Nan Liu; Xun Li; Qing-Zhu Nie; Xiao-Long Chen
Journal:  Int J Ophthalmol       Date:  2010-09-18       Impact factor: 1.779

2.  Corneal endothelial cell loss after trabeculectomy or after phacoemulsification, IOL implantation and trabeculectomy in 1 or 2 steps.

Authors:  María I Soro-Martínez; María P Villegas-Pérez; Paloma Sobrado-Calvo; José M Ruiz-Gómez; Jaime Miralles de Imperial Mora-Figueroa
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2009-10-16       Impact factor: 3.117

3.  Complications and outcomes of primary phacotrabeculectomy with mitomycin C in a multi-ethnic asian population.

Authors:  David Z Chen; Victor Koh; Chelvin Sng; Maria C Aquino; Paul Chew
Journal:  PLoS One       Date:  2015-03-16       Impact factor: 3.240

4.  Effect of Mitomycin-C Augmented Trabeculectomy on Corneal Endothelial Cells.

Authors:  Reza Zarei; Mohammad Zarei; Ghasem Fakhraie; Yadollah Eslami; Sasan Moghimi; Masoud Mohammadi; Ali Abdollahi
Journal:  J Ophthalmic Vis Res       Date:  2015 Jul-Sep

5.  Comparison of 1-Site and 2-Site Phacotrabeculectomy in the Small Adult Eyes With Concomitant Cataract and Glaucoma.

Authors:  Xiaobo Xia; Ying Tian; Zhenkai Wu; Dan Wen; Weitao Song
Journal:  Medicine (Baltimore)       Date:  2016-02       Impact factor: 1.889

6.  Corneal endothelial cell loss after trabeculectomy and phacoemulsification in one or two steps: a prospective study.

Authors:  María Isabel Soro-Martínez; Juan Antonio Miralles de Imperial-Ollero; Miriam Pastor-Montoro; Gabriel Arcos-Villegas; Paloma Sobrado-Calvo; José María Ruiz-Gómez; Jaime Miralles de Imperial-Mora-Figueroa; María Paz Villegas-Pérez
Journal:  Eye (Lond)       Date:  2021-01-07       Impact factor: 3.775

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.